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Background: Acetyl-CoA and propionyl-CoA carboxylases slowly form ethylmalonyl-CoA as a side activity.
Results:Anew enzyme, ethylmalonyl-CoA decarboxylase, was identified inmammalian tissues and shown to be encoded by the
ECHDC1 gene. Knocking down this gene increased the formation of ethylmalonate from butyrate in cultured cells.
Conclusion: Ethylmalonyl-CoA decarboxylase may be a new “metabolite proofreading” enzyme.
Significance: Its deficiency may cause ethylmalonic aciduria.
A limited number of enzymes are known that play a role anal-
ogous toDNAproofreading by eliminatingnon-classicalmetab-
olites formed by side activities of enzymes of intermediary
metabolism. Because few such “metabolite proofreading
enzymes” are known, our purpose was to search for an enzyme
able to degrade ethylmalonyl-CoA, a potentially toxic metabo-
lite formed at a low rate from butyryl-CoA by acetyl-CoA car-
boxylase and propionyl-CoA carboxylase, twomajor enzymes of
lipid metabolism. We show that mammalian tissues contain a
previously unknown enzyme that decarboxylates ethylmalonyl-
CoA and, at lower rates, methylmalonyl-CoA but that does not
act on malonyl-CoA. Ethylmalonyl-CoA decarboxylase is par-
ticularly abundant in brown adipose tissue, liver, and kidney in
mice, and is essentially cytosolic. BecauseEscherichia colimeth-
ylmalonyl-CoA decarboxylase belongs to the family of enoyl-
CoA hydratase (ECH), we searched mammalian databases for
proteins of uncharacterized function belonging to the ECH fam-
ily. Combining this database search approach with sequencing
data obtained on a partially purified enzyme preparation, we
identified ethylmalonyl-CoA decarboxylase as ECHDC1. We
confirmed this identification by showing that recombinant
mouse ECHDC1 has a substantial ethylmalonyl-CoA decarbox-
ylase activity and a lower methylmalonyl-CoA decarboxylase
activity but no malonyl-CoA decarboxylase or enoyl-CoA
hydratase activity. Furthermore, ECHDC1-specific siRNAs
decreased the ethylmalonyl-CoA decarboxylase activity in
humancells and increased the formationof ethylmalonate,most
particularly in cells incubated with butyrate. These findings
indicate that ethylmalonyl-CoA decarboxylase may correct a
side activity of acetyl-CoA carboxylase and suggest that its
mutation may be involved in the development of certain forms
of ethylmalonic aciduria.
Specificity is a remarkable feature of enzymes, compared
with other catalysts, and it is usually assumed that this specific-
ity, although generally not absolute, is high enough in the case
of enzymes of intermediary metabolism to avoid the formation
of significant amounts of side products. Such side products are
unlikely to be metabolized at significant rates; they may there-
fore accumulate and possibly perturb cell physiology. Recent
findings indicate, however, that enzyme specificity is not always
sufficient and that a few enzymes exist that serve to eliminate
non-classical metabolites resulting from the side activity of
enzymes of intermediary metabolism. These enzymes, which
are a variety ofmetabolite repair enzymes (the other ones act on
chemically damaged metabolites (1)), play a role analogous to
that of the proofreading activities that serve to increase the
fidelity of DNA replication and the formation of aminoacyl-
tRNAs. We propose to name them “metabolite proofreading
enzymes.”
A good illustration of the importance of metabolite repair is
the metabolic disorder L-2-hydroxyglutaric aciduria (2). L-2-
Hydroxyglutaric aciduria, a severe neurological disorder (3, 4),
is due to a deficiency in L-2-hydroxyglutarate dehydrogenase, a
mitochondrial enzyme serving to destroy L-2-hydroxyglutarate
(5–7). The latter has no knownmetabolic role but appears to be
formed by mitochondrial L-malate dehydrogenase due to a
minor side activity of this enzyme on -ketoglutarate (8, 9).
This activity amounts to about 107 times less than the main
activity of this enzyme (on oxaloacetate), yet, taking into
account the intracellular concentration of -ketoglutarate, it is
sufficient to account for the formation of several g of L-2-hy-
droxyglutarate per day. The absence of a known role for L-2-
hydroxyglutarate inmammals and its apparent toxicity indicate
that L-2-hydroxyglutarate dehydrogenase plays the role of a
metabolite proofreading enzyme.
A few other examples of metabolite proofreading enzymes
are known. A hydrated form of NADH (NADHX) formed by
glyceraldehyde 3-phosphate dehydrogenase (10–12), is recon-
verted to NADH by an ATP-dependent enzyme (13, 14) that
has recently been molecularly identified (15). The activity of
this widely distributed stereospecific enzyme, which also acts
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on NADPHX, is complemented by an NAD(P)HX epimerase
(15). Furthermore, a GDP-glucose phosphorylase that corrects
a side activity of the GDP-mannose-forming enzyme in mam-
malian cells and Caenorhabditis elegans has been described
(16).
Because few examples of metabolite proofreading enzymes
are known andbecause of the potential importance of this proc-
ess, we decided to actively search for such enzymes. Two
examples of metabolic enzymes displaying an obvious lack of
specificity are propionyl-CoA carboxylase and acetyl-CoA car-
boxylase. Propionyl-CoA carboxylase significantly acts on
butyryl-CoA, which is converted to ethylmalonyl-CoA at a rate
amounting to about 2% of the rate at which propionyl-CoA is
carboxylated (17). Acetyl-CoA carboxylase displays a similar
lack of substrate specificity, being able to synthesizemethylma-
lonyl-CoA and ethylmalonyl-CoA (18–20).
The purpose of the present workwas to search for an enzyme
that would “correct” a side activity of acetyl-CoA and propio-
nyl-CoA carboxylases by breaking down ethylmalonyl-CoA.
We report here that mammalian tissues indeed contain an eth-
ylmalonyl-CoA decarboxylase, an enzyme that has not been
described before. We identify this enzyme as the expression
product of the ECHDC1 (enoyl-CoA hydratase domain con-
taining 1) gene, a member of the enoyl-CoA hydratase family,
and provide evidence for its role in metabolite repair.
EXPERIMENTAL PROCEDURES
Materials—Reagents, of analytical grade whenever possible,
were from Sigma, Acros (Geel, Belgium), Roche Applied Sci-
ence, or Merck. [14C]NaHCO3, DEAE-Sepharose, phenyl-Sep-
harose, andQ-Sepharose resins as well as NAP-5 columnswere
obtained from GE Healthcare. The nickel-NTA Superflow col-
umn was from Qiagen, and the Blue-Trisacryl resin was from
Sigma. Enzymes used for PCR and cloning purposes were
obtained from Fermentas (Sankt Leon-Rot, Germany).
Purification of Ethylmalonyl-CoA Decarboxylase—Frozen
rat liver (10 g) was homogenized with 3 volumes of buffer A
(25 mM Hepes, 5 mM potassium phosphate, both at pH 7.1, 2
g/ml leupeptin, 2 g/ml antipain, and 1 mM dithiothreitol)
containing 100 mM KCl. The homogenate was centrifuged for
10 min at 10,000  g and 4 °C. The resulting supernatant was
enriched with 2% (w/v) PEG and recentrifuged as above. This
supernatant was diluted 2-fold with homogenizing buffer with-
out KCl and loaded onto a DEAE-Sepharose column, and an
NaCl gradient (0–500mM in 2 75ml of buffer A) was applied
to elute the enzymatic activity.
A sample (15 ml) of the purified protein was applied onto a
Blue-Trisacryl column (1.5-ml gel bed). The column was
washed with 5 mM Hepes, 5 mM potassium phosphate, both at
pH 7.1, 2 g/ml leupeptin, 2 g/ml antipain, and 1 mM dithio-
threitol. The protein was eluted with a stepwise salt gradient (0,
100, 200, 300, 400, 500, 600, 800, and 1000mMNaCl in the same
buffer), and 2-ml fractions were collected. The active fractions
(5 ml) were enriched with 0.5 M NaCl and applied onto a
phenyl-Sepharose column (1.5-ml bed volume) equilibrated
with buffer A containing 0.5 M NaCl. The retained proteins
were eluted with a decreasing gradient of NaCl followed by an
increasing gradient of ethylene glycol (0–70%). The most puri-
fied fraction of rat liver ethylmalonyl-CoA decarboxylase
obtained after the three-step purification procedure described
above was digested with trypsin and analyzed by LC-tandem
mass spectrometry essentially as described previously (21).
Tissue Fractionation—Tissue fractionation was performed
by differential centrifugation as described by de Duve et al. (22)
starting from the livers of overnight starved rats, to obtain frac-
tions enriched in mitochondria, lysosomes, or microsomes
(designated fractionsM, L, or P, respectively) and a final super-
natant, containing cytosolic proteins. Marker enzymes were
determined to ensure that the fractionationwas successful. Tri-
ton X-100 (0.1%) was included in all assays, to ensure mem-
brane permeability. This concentration of detergent does not
inhibit ethylmalonyl-CoA decarboxylase. Protein concentra-
tion was determined using the Lowry assay.
Partial Purification of Propionyl-CoA Carboxylase—The
flow-through of the first DEAE-Sepharose column was diluted
2-fold with buffer A and reapplied onto a DEAE-Sepharose col-
umn, which was developed with the same gradient as above.
The enzyme was assayed in the eluted fractions. The most
active fractions were treated with 10% (w/v) PEG. The pellet
was resuspended in one-tenth of the initial volume of buffer A
and applied onto a column of Blue-Trisacryl (2-ml gel bed)
equilibrated with buffer A. The columnwas washed with buffer
A, and proteins were eluted with a salt gradient in the same
buffer. The active fractions were eluted with 750 mM NaCl
and were used to prepare radiolabeled ethylmalonyl-CoA,
methylmalonyl-CoA, and malonyl-CoA.
Preparation of [14C]Ethylmalonyl-CoA—The reaction mix-
ture (1 ml) contained 100 mM Tris, pH 8, 10 mM potassium
phosphate, 1 mM dithiothreitol, 2 mMATP-Mg, 5 mMMgCl2, 1
mMbutyryl-CoA, 40Ci of [14C]NaHCO3 (55mCi/mmol), and
200g of propionyl-CoA carboxylase. 5mM glucose and 2l of
hexokinase were added to arrest the reaction after 15 min of
incubation at 30 °C. The sample was diluted 2-fold in 5 mM
Hepes, pH 7.1, and applied onto a Q-Sepharose column (3 ml)
equilibrated with the same buffer. The radioactivity was eluted
with 5 ml of 150 mM NaCl, followed by 5 ml of 300 mM NaCl.
Wenoted that ethylmalonyl-CoA treatedwith acid to eliminate
unreacted HCO3 was partially resistant to decarboxylation by
ethylmalonyl-CoA decarboxylase, suggesting that it was race-
mized; we therefore avoided the use of an acidification step in
the preparation of [14C]ethylmalonyl-CoA. The yield of radio-
active ethylmalonyl-CoA amounted to 25–40% of the initial
radioactivity. Radiolabeled methylmalonyl-CoA and malonyl-
CoA were prepared similarly but with 0.2 mM propionyl-CoA
and 2 mM acetyl-CoA, respectively.
Chemical Synthesis of Non-labeled Ethylmalonyl-CoA—Eth-
ylmalonyl-CoAwas synthesized according to amodified proce-
dure of Coleman and Huang (23) using acyl adenylate as the
thioacylating reagent. Briefly, ethylmalonyl-AMPwas prepared
from ethylmalonic acid and adenosine monophosphate as fol-
lows. To a solution of ethylmalonic acid (50 mol) in dimeth-
ylformamide and AMP (45mol) was added a solution of dicy-
clohexylcarbodiimide (50 mol) in dimethylformamide with
stirring. The reaction was allowed to proceed for 1 h, and eth-
ylmalonyl-AMP was directly purified by HPLC. Ethylmalonyl-
CoA was prepared by incubating equal amounts of ethylmalo-
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nyl-AMP (2 mol) and CoA (2 mol) in a solution containing
100 mM imidazole (pH 7) for 2 h at room temperature. Finally,
ethylmalonyl-CoA was isolated by HPLC and characterized by
UV and mass spectrometry analyses, whose results were con-
sistent with its structure.
Propionyl-CoA Carboxylase Assay—Samples to be ana-
lyzed (25 l) were incubated with 100 mM Tris, pH 8, 10 mM
potassium phosphate, 1 mM dithiothreitol, 2 mM ATP-Mg, 5
mM MgCl2, 0.2 mM propionyl-CoA, and 100,000 cpm
[14C]NaHCO3 for 20 min at 30 °C in a total volume of 100 l.
The reaction was stopped by the addition of 50 l of 10% (w/v)
trichloroacetic acid and 500 l of water. The mixture was cen-
trifuged, and the resulting supernatant was incubated for 1 h at
37 °C and flushed with air three times at 20-min intervals to
eliminate radioactive CO2. The samples were then counted for
radioactivity.
Ethylmalonyl-CoA Decarboxylase Assay—The enzyme was
assayed through the decrease in acid-stable [14C]ethylmalonyl-
CoA in a reactionmixture at 30 °C containing 20mMHepes, pH
7.1, 1 mM MgCl2, 5 mM ATP-Mg, and 8000 cpm ethylmalonyl-
CoA in a final volume of 100 l. The reaction was stopped with
50 l of 10% trichloroacetic acid, 500 l water was added, and
the samples were incubated at 37 °C for 30 min with flushing.
Control incubations were run without enzyme to take into
account a modest spontaneous decarboxylation (5% in 20
min). One unit of enzyme is the amount that causes 50% deg-
radation of the substrate in 1min in a final volume of 1ml. Note
that the assay is more easily performed bymeasuring the disap-
pearance of ethylmalonyl-CoA than by measuring the appear-
ance of radiolabeled CO2, which requires efficient trapping of
CO2. To measure the enzyme activity in tissues, we chose dilu-
tions allowing us to obtain between 20 and 75% of substrate
conversion. Semilogarithmic plots were used to calculate the
activity.
Preparation of Recombinant Mouse ECHDC1—A 5-primer
containing the ATG codon (CGACATATGGCAAAATGTC-
TTTTGACTTC) in an NdeI site (in boldface type) and a
3-primer containing the putative stop codon (TTTGCGGCC-
GCCTATTTAGTATGCTTTCCTTTCTTA) flanked by a
NotI site were used to PCR-amplify the coding sequence of
ECHDC1 from mouse brain cDNA with Pfu polymerase. An
900-bp product was obtained. This fragment was restricted
with NdeI and NotI and ligated into the pET28a plasmid in
order to express ECHDC1 as an N-terminally His-tagged pro-
tein. The resulting plasmid was checked by sequencing and
used to transform Escherichia coli BL21 cells.
The resulting bacteria were grown in 400ml of Luria-Bertani
(LB) medium containing kanamycin (50 mg/liter). The culture
was grown at 37 °C untilA600 reached 0.5–0.6. After cooling on
ice for 20 min, the inducer isopropyl-1-thio--D-galactopyra-
noside was added to a final concentration of 0.4 mM, and the
culture was pursued at 18 °C for 20 h. The cells were collected
by centrifugation, resuspended in 20ml of lysing buffer (20 mM
Hepes, pH 7.1, 0.5 mM phenylmethylsulfonyl fluoride, 5 g/ml
leupeptin, 5 g/ml antipain, and 1 mg/ml lysozyme), and sub-
mitted to three cycles of freezing and thawing. The bacterial
extract was incubated on ice for 1 h with 0.1 mg/ml DNase I in
the presence of 10 mM MgSO4 and centrifuged for 30 min at
10,000  g. The resulting supernatant (20 ml) was diluted
3-fold with buffer B (25mMHepes, pH 7.4, 5g/ml leupeptin, 5
g/ml antipain, 300 mM NaCl, and 20 mM imidazole) and
loaded onto a nickel-NTA Superflow column (1 ml of resin).
The column was washed with buffer B containing 5 mM imid-
azole until A280 had reached less than 0.01, and the His-tagged
protein was eluted with buffer B containing 250 mM imidazole.
The purified protein was analyzed by SDS-PAGE, desalted on a
NAP-5 column equilibrated with buffer C (25 mM Hepes, pH
7.1, 5 g/ml leupeptin, 5 g/ml antipain, and 100 mM KCl),
supplemented with 10% (v/v) glycerol, and stored at70 °C.
siRNA Transfection of HEK293T Cells and Quantitative
Real-time PCR—HEK293T cells were maintained and trans-
fected with siRNAs as described (16). Control siRNA (Dharma-
con ON-TARGETplus non-targeting pool from Thermo
Scientific (Epsom, UK)) or ECHDC1 siRNA (Dharmacon ON-
TARGETplus SMARTpool fromThermo Scientific) was added
at a final concentration of 50 nM using Lipofectamine 2000
(Invitrogen) as the transfection reagent. After 48–72 h, protein
or total RNA was extracted from cells as described previously
(16). Protein concentration was determined by the Lowry assay
after protein precipitation with 10% trichloroacetic acid, and
RNA concentrations were determined by measuring the
absorbance at 260 nm. Ethylmalonyl-CoA decarboxylase activ-
ity was assayed in the cleared lysates by the method described
above. To measure ECHDC1 mRNA transcript levels, cDNA
synthesis and quantitative real-time PCR were performed as
described previously (16) using RevertAidTM H Minus reverse
transcriptase (Fermentas) and SYBR Green fluorescent dye
(Bio-Rad), respectively. Primers used for amplification can be
obtained upon request.
Assay of Short Chain Acyl-CoAs—Short chain acyl-CoAs
were separated by reverse-phase HPLC using the method
described byDeutsch et al. (24), except that a 5-mPursuit XRs
C18 column, 250 4.6 mm (Varian), was used. Retention times
of methylmalonyl-CoA, ethylmalonyl-CoA, propionyl-CoA,
and butyryl-CoA were 15.5, 18.5, 27.4, and 31.0 min, respec-
tively. The concentration of those compounds in analyzed sam-
ples was calculated by comparison of the corresponding peak
areas with the peak area of a known amount of standard butyryl-
CoA obtained by monitoring UV absorbance at 260 nm.
Assay of Extracellular Ethylmalonate—Cell media (1 ml)
were treated with hydroxylamine hydrochloride in the pres-
ence of mandelic acid as an internal standard. Following acidi-
ficationwithHCl and saturationwithNaCl, extractionwas per-
formed with ethyl acetate and diethyl ether. After evaporation
of the combined extracts under a streamof nitrogen, derivatiza-
tion was achieved with N,O-bis(trimethylsilyl)trifluoroacet-
amide. Analysis was performed by gas chromatography
(Hewlett-Packard 6890 series GC system equipped with a
30 m  0.25-mm fused silica capillary column CP-SIL 8CB
from Varian) with helium as carrier gas, coupled to a Hewlett-
Packard 5973 mass-selective detector under electron impact
fragmentation and with the scan and selective ion monitoring
modes for data acquisition. Ethylmalonic acid was identified
and quantified by comparing its retention time,mass spectrum,
and detector response with those of the commercial com-
pound. For quantification, the extracted ion chromatogram at
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m/z 217 was used after data acquisition in the selective ion
monitoring mode.
RESULTS
Presence of anEnzymeCatalyzing theDecarboxylation of Eth-
ylmalonyl-CoA in Mouse Tissue Extracts—To detect the pres-
ence of a putative ethylmalonyl-CoA decarboxylase, [14C]eth-
ylmalonyl-CoA was prepared by carboxylation of butyryl-CoA
with [14C]HCO3 with partially purified propionyl-CoA car-
boxylase. The resulting ethylmalonyl-CoA was purified by
chromatography on Q-Sepharose. Methylmalonyl-CoA was
prepared similarly starting from propionyl-CoA. The decar-
boxylase activity wasmeasured with these substrates by follow-
ing the disappearance of acid-stable radioactivity. All assays in
crude extracts and during the purification were performed in
the presence of 5 mM ATP-Mg, which we found to slow down
enzymatic hydrolysis of CoA derivatives by pyrophosphatases3;
however, this did cause some inhibition of the decarboxylase
activity (see below). Diluted mouse liver (1:10,000) and white
adipose tissue (1:1000) extracts catalyzed the decarboxylation
of ethylmalonyl-CoA (0.5 M) with first order kinetics and
half-lives of 10 and 20 min, respectively (Fig. 1). About
10-fold slower decarboxylation rates were observed withmeth-
ylmalonyl-CoA than with ethylmalonyl-CoA (Fig. 1). The
decarboxylation rates were proportional with extract concen-
tration, provided appropriate dilutions were used. Because of
the first order kinetics of the decarboxylation rate under our
experimental conditions, one unit was defined as the amount of
enzyme that catalyzes the breakdown of 50% of radioactive eth-
ylmalonyl-CoA per ml in 1 min under the conditions described
(i.e. in the presence of 5 mM ATP-Mg). Calculations applied to
the results shown in Fig. 1 indicated the presence of1000 and
50 units of ethylmalonyl-CoA decarboxylase per g of liver and
white adipose tissue, respectively.
Tissue Distribution, Subcellular Localization, and Partial
Purification of Ethylmalonyl-CoA Decarboxylase—Similar as-
says were performed on extracts from different mouse tissues.
The activities are reported per mg of protein present in the
extracts (Fig. 2). Brown adipose tissue, liver, and kidney con-
tained the highest levels of enzymatic activity. Using this assay,
we also tested the effect of up to 3 days of fasting on the enzy-
matic activity in liver, brown adipose tissue, and kidney. No
significant effect was observed (not shown).
Subcellular fractionation of a rat liver extract prepared from
fresh tissue (22) indicated that the enzyme was essentially
(90%) present in the final high speed supernatant. Specific
activities of 0.13, 0.09, 0.09, and 1.52 units/mg protein (means
of two values differing by less than 15%) were recorded in the
heavy mitochondrial (M), light mitochondrial (L), microsomal
(P), and final supernatant fractions. We verified that the low
activity found in the mitochondrial fraction was not due to
hydrolysis of the substrate by (pyro)phosphatases or deacylases
by checking the behavior of this substrate on anion exchange
chromatography at the end of incubations.
The enzyme was partially purified from a frozen rat liver
extract by successive chromatographic steps on DEAE-Sephar-
ose (Fig. 3), Blue-Trisacryl, and phenyl-Sepharose. These puri-
fication steps allowed us to separate ethylmalonyl-CoA decar-
boxylase from contaminating and potentially interfering
activities such as propionyl-CoA carboxylase and methylmalo-
nyl-CoA racemase. The overall degree of purification over the
original liver extract (3-fold after the DEAE-Sepharose step;
50-fold after the Blue-Trisacryl and the Phenyl-Sepharose
steps) was, however, weak, largely due to loss of activity in each
of the steps. As shown in Fig. 4, the partially purified enzyme
preparation acted upon ethylmalonyl-CoA about 10 times
more rapidly than on methylmalonyl-CoA and not detectably
on malonyl-CoA.
Molecular Identification of Ethylmalonyl-CoADecarboxylase—
Two complementary approaches were used to try to molecu-
larly identify ethylmalonyl-CoA decarboxylase. The first one
was a database search approach, looking for homologous pro-
teins catalyzing a similar reaction. Two such enzymes are
known: malonyl-CoA decarboxylase, an enzyme found in ver-
tebrates, and methylmalonyl-CoA decarboxylase, an enzyme
initially described inE. coli and that is involved in the formation3 E. Van Schaftingen and G. Noël, unpublished results.
FIGURE 1. Time course of ethylmalonyl-CoA decarboxylation in different
tissue extracts. Radiolabeled ethylmalonyl-CoA or methylmalonyl-CoA
(8000 cpm; 0.5 M) was incubated with diluted mouse liver (1:10,000 final
dilution in theassay) orwhite adipose tissue (1:1000) extracts in a final volume
of 100 l. The incubations were arrested at the indicated times by the addi-
tionof trichloroacetic acid. The radioactivity of the sampleswas counted after
eliminationof 14CO2and is representedhereusinga logarithmic scale. Results
represent the means of four values S.E. Ad T, adipose tissue; EMCoA, ethyl-
malonyl-CoA;MMCoA, methylmalonyl-CoA.
FIGURE 2. Tissue distribution of ethylmalonyl-CoA decarboxylase. The
ethylmalonyl-CoA decarboxylase activity was determined with appropriate
dilutions of the extracts prepared from the indicated tissues. The results
are expressed as units/mgprotein in the extract. For the definition of unit, see
“Experimental Procedures.” Data represent the means of 3–4 samples S.E.
(error bars) for each tissue. EMCDC, ethylmalonyl-CoA decarboxylase; Ad T,
adipose tissue; Sk, skeletal.
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of propionyl-CoA from succinyl-CoA. Except formalonyl-CoA
decarboxylase itself, no homologous protein of malonyl-CoA
decarboxylase was found inmammalian genomes. E. colimeth-
ylmalonyl-CoA decarboxylase (25) belongs to the family of
enoyl-CoA hydratases. The human genome encodes 14 pro-
teins belonging to this family. Among these proteins, only three
remain functionally uncharacterized (ECHDC1, ECHDC2, and
ECHDC3). Blast searches indicated that none of the three pro-
teins seemed to be closer to E. colimethylmalonyl-CoA decar-
boxylase than other proteins of the same family, indicating that
none of them qualified as an obvious ortholog of the E. coli
protein.However, the prediction formitochondrial localization
by TargetP (26) was much stronger in the case of ECHDC2 and
ECHDC3 (0.85–0.90 for the human and mouse proteins) than
in the case of ECHDC1 (0.220 and 0.435 for the mouse and
human proteins, respectively), suggesting that ECHDC1 is a
better candidate for ethylmalonyl-CoA decarboxylase, a cyto-
solic protein, than the other two proteins. In addition, the tissue
distribution of ECHDC1mRNA, as available at BioGPS (avail-
able on the World Wide Web), correlated better (r  0.9430;
p 0.0004; 6 degrees of freedom)with the tissue distribution of
the ethylmalonyl-CoA decarboxylase activity than those of
ECHDC2 (r  0.6831, non-significant) and ECHDC3 (r 
0.1676, non-significant).
The second approachwas to determine by liquid chromatog-
raphy coupled to tandemmass spectrometry the identity of the
proteins contained in the most purified fraction of ethylmalo-
nyl-CoA decarboxylase from rat liver. Among 75 hits for which
at least two distinct peptides were identified, ECHDC1 was
present in the 14th position and ECHDC2 in the 49th position
in terms of Sequest identification score, whereas ECHDC3 was
absent. ECHDC1 was the fourth hit in terms of sequence
coverage (33%), whereas ECHDC2 ranked 40th (11%) based on
this criterion. Taken together, these findings indicated that
ECHDC1 is an excellent candidate for ethylmalonyl-CoA
decarboxylase, as was indeed confirmed by characterization of
the recombinant enzyme (see below).
Blast searches indicated that ECHDC1 orthologs (i.e. pro-
teins that are significantly closer to human ECHDC1 than to
any other human protein) are present in all vertebrates whose
genomes have been sequenced (mammalian genomes, Gallus
gallus, Xenopus, fishes) and in several invertebrates like the sea
urchin (Strongylocentrotus purpuratus), Tribolium castaneum,
the shoulder tick (Ixodes scapularis), Ciona intestinalis, Bran-
chiostoma floridae, and C. elegans. It is apparently absent from
Drosophila, as indicated by the finding that the closest homolog
shows less than 30% sequence identity with mammalian
ECHDC1 and is much closer to human ECHDC2 than to
human ECHDC1.
Fig. 5 shows an alignment of rat ECHDC1 with enzymes of
the same family. The N-terminal region of the protein is not
very conserved, which could have suggested the presence of a
mitochondrial propeptide. However, two of the peptides iden-
tified by mass spectrometry in the protein purified from rat
liver corresponded to this non-conserved region, indicating
that it was not removed from the protein in vivo.
Characterization of Recombinant ECHDC1—The cDNA
sequence encoding the full-lengthmouse proteinwas amplified
frommouse brain cDNAand inserted into an expression vector
(pET28a) with an N-terminal poly-His tag. The protein was
expressed for 20 h at 18 °C and purified to homogeneity by
metal affinity chromatography. SDS-PAGE analysis indicated
that the protein had, as expected, a subunit molecular mass of
34 kDa. The homogeneous recombinant enzyme had a spe-
cific activity of 8800 units/mg protein, which is 100-fold
higher than the specific activity of the most purified prepara-
tion from liver. AnHPLCassaywas used to verify that ECHDC1
catalyzes the decarboxylation of ethylmalonyl-CoA. As shown
in Fig. 6, the enzyme converted ethylmalonyl-CoA andmethyl-
malonyl-CoA to products that co-migrated with butyryl-CoA
and propionyl-CoA, respectively.
Chemically synthesized ethylmalonyl-CoA andmethylmalo-
nyl-CoAmust bemixtures of S- andR-isomers in roughly equal
amounts, which, unfortunately, are not separated with the
HPLC procedure that we used (see Fig. 6). It is likely that the
enzyme catalyzes preferentially the decarboxylation of one of
the two isomers. Evidence for this was obtained by performing
decarboxylation assays with different enzyme concentrations.
We obtained a clearly biphasic curve with chemically synthe-
sized ethylmalonyl-CoA (Fig. 7A), suggesting that the two iso-
mers are consumed with activities differing by 2 orders
of magnitude. Propionyl-CoA carboxylase synthesizes the
S-isomer of methylmalonyl-CoA (27) and presumably also of
ethylmalonyl-CoA. Similar “titrations” with different concen-
FIGURE 3. Purification of ethylmalonyl-CoA decarboxylase from rat liver
by chromatography on DEAE-Sepharose. Shown is the first chromato-
graphic step of the purification procedure. 3-ml fractions were collected. For
additional details, see “Experimental Procedures.” EMCDC, ethylmalonyl-CoA
decarboxylase.
FIGURE 4. Decarboxylation of [14C]ethylmalonyl-CoA, [14C]methylmalo-
nyl-CoA, and [14C]malonyl-CoA by rat liver ethylmalonyl-CoA decarbox-
ylase. Radiolabeled ethylmalonyl-CoA, methylmalonyl-CoA, and malonyl-
CoA were incubated with partially purified rat liver ethylmalonyl-CoA
decarboxylase (1.5 units/ml), and decarboxylation was quantified as
described for the tissue extracts in legend to Fig. 1. Results are representative
of two independent experiments.
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trations of recombinant ethylmalonyl-CoA decarboxylase were
performed using radiolabeled ethylmalonyl-CoA produced by
propionyl-CoA carboxylase or with a mixture of epimers
obtained by heating this enzymatically synthesized ethylmalo-
nyl-CoA at 100 °C for 15 or 30 min (28). As shown in Fig. 7B, a
monophasic curve was obtained with (S)-ethylmalonyl-CoA,
whereas a biphasic curve was observed with the mixture of
epimers. From these data, we conclude that ethylmalonyl-CoA
decarboxylase preferentially uses (S)-ethylmalonyl-CoA but
that it has also some activity on the R-form. To rule out the
FIGURE 5. Alignment of ECHDC1 from rats, humans, and X. laevis. The underlined peptides have been identified by MS/MS analysis of a purified fraction of
rat liver ethylmalonyl-CoA decarboxylase. The following sequences are shown: Rattus norvegicus NP_001007735.1 (Ratnor), Homo sapiens NP_001002030
(Homsap), and X. laevis NP_001088953.1 (Xenlae). Residues that are conserved in the three sequences are indicated in boldface type.
FIGURE 6. Formation of butyryl-CoA from ethylmalonyl-CoA and of propionyl-CoA from methylmalonyl-CoA catalyzed by ECHDC1. 22 M
ethylmalonyl-CoA or methylmalonyl-CoA was incubated at 30 °C without or with recombinant ECHDC1 at the indicated concentrations, and the
incubations were arrested after 20 min by the addition of perchloric acid. After adjusting the pH to about 4.5 with K2CO3, samples were analyzed by the
reverse-phase HPLC method described under “Experimental Procedures.” Shown are HPLC chromatograms obtained by monitoring UV absorbance at
260 nm. Eluting peaks were identified by comparing their retention time and UV absorption spectra with standard compounds. EMCoA, ethylmalonyl-
CoA; MMCoA, methylmalonyl-CoA.
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possibility that ethylmalonyl-CoA decarboxylase uses the
R-form because of a contamination of the preparation with
methylmalonyl-CoA epimerase, a metalloenzyme, we preincu-
bated the purified enzyme preparation with EDTA for up to
16 h. This enzyme preparation still decarboxylated both forms
of ethylmalonyl-CoA (results not shown).
We determined the Km of recombinant ECHDC1 for eth-
ylmalonyl-CoA using enzymatically synthesized radiola-
beled ethylmalonyl-CoA and methylmalonyl-CoA together
with variable concentrations of the chemically synthesized
unlabeled compounds, which we assumed to be mixtures of
the two epimers in equal amounts. As shown in Table 1,
ethylmalonyl-CoA decarboxylase showed a Km for (S)-ethyl-
malonyl-CoA of 1 M and a kcat of 10 s1 in the absence
of ATP-Mg. For (S)-methylmalonyl-CoA, the Km was about
3-fold higher, and the Vmax (kcat) was about 6-fold lower.
Thus, ethylmalonyl-CoA was an about 20-fold better sub-
strate for ECHDC1 than methylmalonyl-CoA in terms of
catalytic efficiency, in agreement with the difference in
activities observed with the enzyme purified from rat liver
(see Fig. 4). The presence of ATP-Mg increased the Km for
both substrates without affecting the maximal activity, indi-
cating that ATP-Mg acts as a competitive inhibitor. Other
experiments performed with ethylmalonyl-CoA as a sub-
strate indicated a Ki of 1 mM for ATP-Mg. No inhibition
was observed with GTP-Mg (not shown). Although we used
1 mM Mg2	 in most of our enzymatic assays to mimic phys-
iological conditions, we found that Mg2	 had no effect on
the activity of recombinant ECHDC1, which was also virtu-
ally unaffected by the presence of 1 mM EDTA (not shown).
We also checked whether recombinant ECHDC1 can act as
an enoyl-CoAhydratase.Using a spectrophotometric assay (29)
containing 30 M butenoyl-CoA as a substrate, we did not
detect any activity, leading us to conclude that the enoyl-CoA
hydratase activity of ECHDC1, if any, amounts to less than 1⁄1000
of its ethylmalonyl-CoA decarboxylase activity.
Confirmation of the Identity of Ethylmalonyl-CoA Decarbox-
ylase through an siRNA Approach and Effect on the Concen-
tration of Ethylmalonate—Ethylmalonyl-CoA decarboxylase
activity was also present in HEK293T cell extracts. To verify
that this enzyme was indeed encoded by the ECHDC1 gene, we
transfected HEK293T cells with an siRNA pool specifically tar-
geting this gene. As shown in Fig. 8A, an about 3-fold decrease
in ECHDC1 mRNA levels was measured in HEK293T cells
transfected with ECHDC1 siRNA compared with cells treated
with non-targeting control siRNA, independently of the refer-
ence gene used for normalization purposes (GAPDH or ACTB
(-actin)). This decrease in ECHDC1mRNAwas accompanied
by an average decrease of about 50% in the ethylmalonyl-CoA
decarboxylase activity (Fig. 8B). The knockdown efficiency in
these experiments varied from40 to 70% in terms of activity and
even reached up to 85% in the loading experiments described
below. We assume that this variability is mostly due to differ-
ences in cell confluence at the time of siRNA transfection, a
lower cell confluence favoring knockdown efficiency in the
case of the ECHDC1 gene. These results confirm the identifica-
tion of ethylmalonyl-CoA decarboxylase as the expression
product of the ECHDC1 gene.
To confirm that ethylmalonyl-CoA is a substrate of the
ECHDC1 enzyme in the living cell, we tested whether knocking
down the ECHDC1 gene leads to increased ethylmalonic acid
concentration in the medium of HEK293T cells incubated in
the absence or presence of potential precursors (5mM butyrate,
5 mM L-isoleucine, or 1 mM L-alloisoleucine). Extracellular eth-
ylmalonate concentrations were very low compared with the
concentration of other organic acids in the cell media, and eth-
ylmalonate could only be detected when using the selected ion
mode in our GC-MS method. As shown in Fig. 9A, a small
increase in signal intensity could be detected in the extracted
ion chromatogram for ion m/z 217 (a major ion in the mass
spectrum of derivatized ethylmalonic acid) at the retention
time of ethylmalonic acid (9.0 min) in the media of cells trans-
fected with ECHDC1 siRNA compared with cells treated with
control siRNA. A 24-h incubation with butyrate led to a more
than 2-fold increase in the extracellular concentration of ethyl-
FIGURE 7. Evidence that recombinant ethylmalonyl-CoA decarboxylase
acts preferentially on (S)-ethylmalonyl-CoA. A, chemically synthesized
ethylmalonyl-CoA (22 M) was incubated with the indicated concentrations
of recombinant ECHDC1 as described in the legend to Fig. 6. Ethylmalonyl-
CoA consumption andbutyryl-CoA formationwere determinedbyHPLC. The
results shown are representative of three independent experiments. B, enzy-
matically synthesized [14C]ethylmalonyl-CoA was used as such (open circles)
or after racemization by incubation for 15 min (closed triangles) or 30 min
(open squares) at 100 °C. Both typesof substrateswere incubated for 20minat
30 °C in the presence of the indicated concentrations of recombinant
ECHDC1, and the residual acid-stable radioactivity was measured. Results
represent the mean of three values S.E. EMCoA, ethylmalonyl-CoA.
TABLE 1
Kinetic properties of recombinant ECHDC1
The values are given for the S-form of the substrates, assuming that the chemically
synthesized compounds comprise 50% of the two forms.
Substrate [ATP-Mg] Km kcat kcat/Km
mM M s1 M1 s1
(S)-Ethylmalonyl-CoA 0 0.96 0.08 9.5 0.3 9.9 106
(S)-Ethylmalonyl-CoA 5 6.5 0.5 10.0 0.4 1.5 106
(S)-Methylmalonyl-CoA 0 3.1 0.5 1.61 0.10 0.51 106
(S)-Methylmalonyl-CoA 5 15.1 0.7 1.68 0.03 0.11 106
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malonate in control cells and to a 5-fold increase in ECHDC1
knockdown cells (Fig. 9, B and C).
L-Alloisoleucine is formed in small amounts during transam-
ination of L-isoleucine (30), and itsmetabolism (through a path-
way similar to that of valine metabolism) has been suggested to
lead to the formation of ethylmalonyl-CoA via 2-ethylhydrac-
rylate (31). Although we could detect ethylhydracrylate in the
medium of cells incubated with L-alloisoleucine (not shown),
no increases or onlyminimal increases in extracellular ethylma-
lonate were measured in this condition whether for control or
ECHDC1 knockdown cells (Fig. 9C). Similar results were
obtained when L-isoleucine was added to the cell culture media
(Fig. 9C).
DISCUSSION
Establishment of the Activity of ECHDC1 as Ethylmalonyl-
CoA Decarboxylase—We report the existence of a new enzyme
that converts ethylmalonyl-CoA to butyryl-CoA and CO2. It
also catalyzes a similar reaction on methylmalonyl-CoA but
with an about 20-fold lower catalytic efficiency. We also pro-
vide evidence that it acts on the ethylmalonyl-CoA form that is
produced by propionyl-CoA carboxylase (i.e. the S-isomer, by
analogywith the normal product of this enzyme, (S)-methylma-
lonyl-CoA) (27). The new enzyme does not act detectably on
malonyl-CoA and is thus different from malonyl-CoA decar-
boxylase. It is therefore best described as being an ethylmalo-
nyl-CoA decarboxylase.
We show that this enzyme is encoded by the ECHDC1 gene.
Suggestive evidence came from the observations that ECHDC1
is present in partially purified ethylmalonyl-CoAdecarboxylase
and that the mouse tissue distribution of the activity of ethyl-
malonyl-CoA decarboxylase is similar to that of the ECHDC1
mRNA. The proof for this identification was provided by show-
ing that recombinant ECHDC1 catalyzes the same reaction as
ethylmalonyl-CoA decarboxylase purified from rat liver and
that it is also more active on ethylmalonyl-CoA than on meth-
ylmalonyl-CoA and inactive on malonyl-CoA. Furthermore,
the ethylmalonyl-CoA decarboxylase activity present in human
cells could be knocked down by using ECHDC1-specific
siRNAs.
ECHDC1 belongs to the family of enoyl-CoA hydratases.
The latter comprises a series of enzymes catalyzing diverse
reactions on acyl-CoAs, including hydration (enoyl-CoA
hydratase), isomerization, thioester bond hydrolysis (3-hy-
droxyisopropionyl-CoA hydrolase), and decarboxylation
(methylmalonyl-CoA decarboxylase) (see Ref. 32 for a
review). We verified that ECHDC1 has no crotonyl-CoA
hydratase activity. Furthermore, the quantitative conversion
of ethylmalonyl-CoA to butyryl-CoA that we measured with
ECHDC1 in this study indicates that it has no thioesterase
activity. The common feature of all enzymes of the enoyl-
CoA hydratase family is that the catalytic mechanism pro-
ceeds via a thiolate anion (32).
It is interesting to compare ECHDC1 with the other decar-
boxylase that has been described in this family, namely E. coli
methylmalonyl-CoA decarboxylase (25, 33). The latter was
identified as an enzyme belonging to an operon permitting the
formation of propionate from succinyl-CoA by the successive
action of methylmalonyl-CoA mutase (Sbm), methylmalonyl-
CoA decarboxylase (YgfG), and propionyl-CoA:succinate-CoA
transferase (YgfH). Because there is apparently no methylma-
lonyl-CoA epimerase encoded by the E. coli genome (33), we
presume that methylmalonyl-CoA decarboxylase is acting on
the isomer that is produced bymethylmalonyl-CoAmutase (i.e.
the R-isomer), whereas, as mentioned above, mammalian eth-
ylmalonyl-CoA decarboxylase acts on the S-isomer. This may
explain that, despite belonging to the same protein family,
E. coli YgfG and mammalian ECHDC1 show low degrees of
identity with each other. As a matter of fact, YgfG is not closer
to ECHDC1 than it is to other mammalian members of the
enoyl-CoA hydratase family catalyzing very different reactions.
It is also interesting to compare the catalytic efficiency of
recombinant mouse ECHDC1 in its action on ethylmalonyl-
CoA (Table 1) with that of E. coli methylmalonyl-CoA decar-
boxylase on methylmalonyl-CoA (1.2 105 M1 s1) (33). The
80 times higher value observed with the former enzyme sup-
ports the idea that ethylmalonyl-CoA decarboxylation is the
physiological activity of ECHDC1.
Is Ethylmalonyl-CoA Decarboxylase Involved in the Metabo-
lism of Alloisoleucine?—A potential source of ethylmalonate
and ethylmalonyl-CoA is alloisoleucine. This non-standard
amino acid is formed through epimerization of the -carbon
during transamination of isoleucine (30). Itsmetabolism,which
FIGURE8.Effect ofECHDC1 siRNAonECHDC1mRNA levels and theethylmalonyl-CoAdecarboxylase activity inhumancells.HEK293T cell cultureswere
stopped 48–72 h after siRNA transfection. A, quantitative RT-PCR was performed on cDNA derived from these cells to measure ECHDC1mRNA levels. ECHDC1
expression was normalized to the abundance of GAPDH (black bars) and ACTB (-actin; gray bars) mRNAs and -fold changes in expression levels in ECHDC1
versus control siRNA-transfected cells were calculated using the 2

Ctmethod. B, ethylmalonyl-CoA decarboxylase activity wasmeasured in protein extracts
derived from these cells by the radioactive assay. The results shown represent themeans S.E. (error bars) of four biological replicates. EMCDC, ethylmalonyl-
CoA decarboxylase.
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represents an undefined, presumably small fraction of L-isole-
ucine metabolism, seems to proceed initially in a similar man-
ner to the metabolism of L-valine, in that the methyl branch
rather than the ethyl branch (as in the normal metabolism of
isoleucine) is oxidized. This leads successively to the formation
of ethylacrylyl-CoA (an enoyl-CoA), ethylhydracrylyl-CoA (a
3-hydroxyacyl-CoA), ethylhydracrylate, and ethylmalonate
semialdehyde (Fig. 10). Although most of the indicated reac-
tions have not been studied in vitro, indirect evidence supports
this sequence of reactions as well as the identity of the enzymes
suggested in Fig. 10. Thus, patients with 3-hydroxyisobutyric
aciduria, which is presumably due to 3-hydroxyisobutyrate
dehydrogenase deficiency, often show also accumulation of
ethylhydracrylate (34), indicating that 3-hydroxyisobutyrate
dehydrogenase is involved in ethylhydracrylatemetabolism but
implying also that ethylhydracrylyl-CoA is hydrolyzed before
its alcohol function is oxidized.
The analogy with the L-valine pathway appears to stop at
the level of (m)ethylmalonate semialdehyde oxidation. The
valine catabolite is oxidized by methylmalonate semialde-
hyde dehydrogenase (ALDH6A1), a mitochondrial enzyme
that oxidizes the aldehyde group by converting it to an acyl-
CoA ester, while at the same time removing the initial car-
boxylic group and leading therefore to propionyl-CoA (35).
Goodwin et al. (35) mention that methylmalonate semialde-
hyde dehydrogenase has no activity on ethylmalonate semial-
dehyde. By contrast, in vivo tracer studies obtained with
2-[13C]methylbutyrate labeled on the first carbon or the
2-methyl carbon suggest that ethylmalonate semialdehyde
loses its first carbon during conversion to butyryl-CoA (36).
The two findings can be reconciled by admitting the existence
of a dehydrogenase catalyzing on ethylmalonate semialdehyde
a similar reaction as the one catalyzed bymethylmalonate semi-
aldehyde dehydrogenase on its substrate (Fig. 10). Alterna-
tively, a dehydrogenase could convert ethylmalonate semialde-
hyde to ethylmalonate, and the latter, a prochiral compound,
could be stereospecifically activated to ethylmalonyl-CoA and
decarboxylated by ECHDC1 (Fig. 10). However, nothing pre-
cise is known about the dehydrogenase that acts on ethylma-
lonate semialdehyde and about the enzyme(s) that could acti-
vate ethylmalonate to ethylmalonyl-CoA.
Many data point to the sluggishness of this “alternative”
pathway of isoleucine metabolism. The finding that ethylhy-
dracrylic acid accumulates when the normal pathway of isoleu-
cinemetabolism is blocked at the level of 2-methylbutyryl-CoA
dehydrogenase suggests that the alternative R-pathway is not
very efficient (37). This is also indicated by the finding that
loading with (R,S)-2-methylbutyric acid, a precursor of one of
the early intermediates in this pathway, leads to massive excre-
tion of ethylhydracrylic acid, amounting to about 40% of the
administered (R)-2-methylbutyric acid (36). Our own data do
not support a role of ethylmalonyl-CoA decarboxylase in the
metabolism of L-alloisoleucine. The subcellular localization of
this enzyme does not fit with that (mitochondrial) of the known
enzymes involved in L-alloisoleucine metabolism. Further-
more, the addition of this amino acid to cell cultures did not
cause any detectable increase in the concentration of ethylma-
lonate, whether in control or ECHDC1 knockdown cells,
whereas it did cause an increase in ethylhydracrylic acid, indi-
cating that L-alloisoleucine wasmetabolized. However, we can-
not exclude the possibility that this absence of increase in the
ethylmalonate concentration is due to the absence of appropri-
ate enzymes for the oxidation of ethylmalonate semialdehyde in
HEK293T cells.
FIGURE 9. Consequences of knocking down ECHDC1 activity on the con-
centration of ethylmalonate in the medium of cells challenged with
butyrate, L-isoleucine and L-alloisoleucine. Butyrate (5mM), L-isoleucine (5
mM), and L-alloisoleucine (1mM)were added to the culturemedia of HEK293T
cells that had been transfected with control or ECHDC1 siRNAs 48 h earlier.
Cultures were stopped 24 h after medium supplementation; protein extracts
were prepared from cells for ethylmalonyl-CoA decarboxylase activity mea-
surements, and organic acids were extracted from the corresponding media
for subsequent GC-MS analysis. An average knockdown efficiency of about
75% was obtained for ethylmalonyl-CoA decarboxylase activity in these
experiments. A and B show overlays of extracted ion chromatograms (m/z
217) obtained for media of control siRNA-treated cells (black line) or ECHDC1
siRNA-treated cells (red line) incubated in the absence (A) or presence of 5mM
butyrate (B). Standard ethylmalonic acid eluted at 9.0 min in the GC-MS
method used. C represents the concentrations of extracellular ethylmalonate
measured for control (white bars) or ECHDC1 knockdown (graybars) cells incu-
bated in the absence or presence of the indicated compounds. Peak areas of
the extracted ion current were used for ethylmalonate quantification except
when L-isoleucine was used for medium supplementation. In the latter con-
dition, a 2-keto-3-methylvaleric acid (transamination product of L-isoleucine)
derivative generated a peak overlapping with the ethylmalonate peak, and
consequently peak height rather than peak area was used for ethylmalonate
quantification. The concentrations shown represent the means  S.E. (error
bars) of three biological replicates. L-Allo-Ile, L-alloisoleucine.
Ethylmalonyl-CoADecarboxylase, aMetabolite Repair Enzyme
43000 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 286•NUMBER 50•DECEMBER 16, 2011
 at UNIVERSITE CATHO
LIQUE LOUVAIN, on Decem
ber 9, 2011
w
w
w
.jbc.org
D
ow
nloaded from
 
Metabolite Proofreading Role of Ethylmalonyl-CoA Decar-
boxylase—As mentioned in the Introduction, ethylmalonyl-
CoA can be formed in vitro both by acetyl-CoA carboxylase
(20), a cytosolic enzyme, and by propionyl-CoA carboxylase
(17), a mitochondrial enzyme. Our hypothesis that ethylmalo-
nyl-CoA decarboxylase serves to eliminate ethylmalonyl-CoA
made frombutyryl-CoA is supported by our finding that knock-
ing down ECHDC1 with siRNAs increases severalfold the for-
mation of ethylmalonate in cells incubated with butyrate. The
ethylmalonyl-CoA that accumulates under such conditions is
presumably hydrolyzed by thioesterases present in cells.
Wewere initially surprised by two properties of the ethylma-
lonyl-CoA decarboxylase: its main localization in the cytosol,
which accounts for more than 90% of the enzymatic activity,
and its relative lack of specificity, because it acts also on meth-
ylmalonyl-CoA. As amatter of fact, both properties are related;
a highmitochondrialmethylmalonyl-CoAdecarboxylase activ-
ity would cause a futile cycle with propionyl-CoA carboxylase.
This also means, however, that metabolite repair of ethylmalo-
nyl-CoA essentially occurs in the cytosol, mainly compensating
for the lack of specificity of acetyl-CoA carboxylase (Fig. 11).
Furthermore, the enzyme is also able to eliminate cytosolic
methylmalonyl-CoA, which is potentially formed from cytoso-
lic propionyl-CoA by acetyl-CoA carboxylase.
The presence of ethylmalonyl-CoA decarboxylase in the
cytosolmay prevent perturbation of lipid synthesis by fatty acid
synthase (Fig. 11). Ethylmalonyl-CoA andmethylmalonyl-CoA
could perturb this process merely by trapping CoA, by inhibit-
ing fatty acid synthase due to their structural similarity with
malonyl-CoA, or even by being used by fatty acid synthase,
leading then to the formation of fatty acids with ethyl ormethyl
branches. The presence of fatty acids with methyl and ethyl
branches has been described on the feathers of birds (38) and
in the fleece of cashmere goats (39), respectively. The forma-
tion of methyl-branched fatty acids from methylmalonyl-
CoA by fatty acid synthase has been demonstrated in goose
uropygial gland extracts (40). The formation of branched
fatty acids by fatty acid synthase is favored in these glands by
the presence of a highly active malonyl-CoA decarboxylase,
which does not act on methylmalonyl-CoA and thereby specif-
ically depletes the malonyl-CoA pool (41). Ethylmalonyl-CoA
decarboxylase might reciprocally prevent the formation of
methyl or ethyl branches by depleting the cytosolic pool of
(m)ethylmalonyl-CoA.
Phenotype Expected in Ethylmalonyl-CoA Decarboxylase
Deficiency?—Absence of ethylmalonyl-CoA decarboxylase is
expected to cause an increase in ethylmalonic acid concentra-
tion and to be therefore a cause of ethylmalonic aciduria. Two
different enzymatic defects are presently known to cause
abnormal excretion of ethylmalonic acid. The first one is a
defect in short chain acyl-CoA dehydrogenase (SCAD) (42), an
enzyme that serves to metabolize butyryl-CoA (Fig. 11). The
abnormal excretion of ethylmalonate is easily explained in the
following manner. The block in the oxidation of butyryl-CoA
causes a rise in its concentration and thereby stimulates its “ille-
gitimate” carboxylation by acetyl-CoA carboxylase and propi-
onyl-CoA carboxylase.
This explanation is certainly partially true, andmany patients
with ethylmalonic aciduria have been found to have mutations
in the SCAD gene that cause marked alterations in the kinetic
properties of this enzyme. However, two of the frequent “muta-
tions” that have been found in this disorder have minimal
effects on the kinetic properties of the enzyme and are largely
present in the normal population. 6% of normal people are
FIGURE 10. Comparative metabolism of L-valine, L-isoleucine, and L-alloisoleucine and formation of ethylmalonate from L-alloisoleucine. Enzymes
involved in the different reactions are indicated by the human gene names. ACAD8, isobutyryl-CoA dehydrogenase; ACADSB, short/branched chain acyl-CoA
dehydrogenase; ACAT1, acetyl-CoA acetyltransferase 1; ALDH6A1, methylmalonate semialdehyde dehydrogenase; BCAT1/2, branched chain amino acid trans-
aminase 1 or 2; BCKDHA/B, branched chain keto acid dehydrogenase; ECHS1, short chain enoyl-CoA hydratase;HIBADH, 3-hydroxyisobutyrate dehydrogenase;
HIBCH, 3-hydroxyisobutyryl-CoA hydrolase; HSD17B10, 2-methyl-3-hydroxybutyryl-CoA dehydrogenase.
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homozygous for the mutation that has been most frequently
found in ethylmalonic aciduria (42). One potential explanation
for this discrepancy could be that ethylmalonic aciduria devel-
ops in patients with these hypoactive variants of SCAD only if
these variants are combined with a defect in ethylmalonyl-CoA
decarboxylase. It would bemost interesting to search for muta-
tions in the ECHDC1 gene in such patients.
A second important cause of ethylmalonic aciduria is known
as ethylmalonic encephalopathy. This more severe condition is
due to a defect in an enzyme (ETHE1) involved in sulfurmetab-
olism. The accumulation of HS leads to multiple metabolic
alterations (43), including defects in complex IV and in short
chain acyl-CoA dehydrogenase. The latter is thought to be
responsible for the accumulation of ethylmalonate, as de-
scribed above for the genetic alterations in the SCAD gene. We
have checked if ethylmalonyl-CoA decarboxylase is inhibited
by HS and found no effect.3
Isolated ethylmalonyl-CoA decarboxylase deficiency could
lead to a third form of ethylmalonic aciduria. It is expected that
in this case, no enhanced excretion of butyrylcarnitine or
butyrylglycinewould be observed.One expectation is, however,
that this disorder might be accompanied by the accumulation
of abnormal, ethyl-branched fatty acids.Whether this would be
an isolated biochemical anomaly or whether it would lead to
major pathophysiological perturbations is difficult to predict.
In conclusion, ethylmalonyl-CoA decarboxylase is a new
enzyme, which we postulated to exist based on the metabolite
proofreading hypothesis. We provide evidence for the fact that
one of the roles of this enzyme, maybe its exclusive role, is
indeed to “correct” ethylmalonyl-CoA formed by acetyl-CoA
carboxylase. This enzyme is likely to be mutated in an as yet
undescribed form of ethylmalonic aciduria, whichwould there-
fore qualify as a new disorder of metabolite proofreading.
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